QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)
QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)
QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)
QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
C$0.01
C$0.01
C$0.01
C$0.02
C$1.85MN/A317,764 shs26,000 shs
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
$0.11
$0.10
$0.08
$11.50
N/AN/AN/A867,698 shs
Valaris Limited stock logo
VAL
Valaris
$68.98
-1.2%
$68.98
$54.13
$78.92
$4.99B1.13899,172 shs52,913 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
0.00%0.00%0.00%0.00%0.00%
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
0.00%0.00%0.00%0.00%0.00%
Valaris Limited stock logo
VAL
Valaris
-1.43%-3.85%-1.36%+7.05%+5.80%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/AN/AN/AN/AN/AN/AN/AN/A
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/AN/AN/AN/AN/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
3.5199 of 5 stars
3.52.00.00.02.71.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/AN/AN/AN/A
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
3.00
Buy$100.0044.97% Upside

Current Analyst Ratings

Latest MTFB, VAL, BPH, PYC, and MFS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/5/2024
Valaris Limited stock logo
VAL
Valaris
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$105.00 ➝ $102.00
2/23/2024
Valaris Limited stock logo
VAL
Valaris
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$107.00 ➝ $105.00
2/14/2024
Valaris Limited stock logo
VAL
Valaris
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$106.00 ➝ $105.00
(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
C$2.23M0.83C$0.00 per share10.00C($0.07) per share-0.15
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/AN/AN/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
$1.78B2.80$2.46 per share28.05$27.40 per share2.52

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/A-C$0.01N/AN/AN/AN/AN/AN/A
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/AN/A0.00N/AN/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
$865.40M$11.695.906.65N/A48.50%5.71%2.40%5/2/2024 (Confirmed)

Latest MTFB, VAL, BPH, PYC, and MFS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Valaris Limited stock logo
VAL
Valaris
$0.40N/A-$0.40N/AN/AN/A  
2/21/2024Q4 2023
Valaris Limited stock logo
VAL
Valaris
$0.29$0.61+$0.32-$10.08$484.00 million$483.80 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/AN/AN/AN/AN/A
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/AN/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/A
0.04
0.03
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
0.54
1.71
1.71

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/A
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/A
Valaris Limited stock logo
VAL
Valaris
96.74%

Insider Ownership

CompanyInsider Ownership
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/A
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/A
Valaris Limited stock logo
VAL
Valaris
0.11%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
7184.98 millionN/ANot Optionable
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
7N/AN/ANot Optionable
Valaris Limited stock logo
VAL
Valaris
5,98572.41 million72.33 millionOptionable

MTFB, VAL, BPH, PYC, and MFS Headlines

SourceHeadline
Interocean announces UT technology demonstrationInterocean announces UT technology demonstration
zawya.com - April 16 at 8:33 AM
Mutual of America Capital Management LLC Acquires 38,367 Shares of Valaris Limited (NYSE:VAL)Mutual of America Capital Management LLC Acquires 38,367 Shares of Valaris Limited (NYSE:VAL)
marketbeat.com - April 14 at 6:11 AM
Valaris Schedules First Quarter 2024 Earnings Release and Conference CallValaris Schedules First Quarter 2024 Earnings Release and Conference Call
businesswire.com - April 11 at 4:30 PM
Aramco Suspends Valaris Rig ContractAramco Suspends Valaris Rig Contract
rigzone.com - April 11 at 1:38 AM
Valaris (VAL) Receives Rigs Suspension Notice From AramcoValaris (VAL) Receives Rig's Suspension Notice From Aramco
zacks.com - April 9 at 2:26 PM
Lancaster Investment Management Buys Shares of 400,116 Valaris Limited (NYSE:VAL)Lancaster Investment Management Buys Shares of 400,116 Valaris Limited (NYSE:VAL)
marketbeat.com - April 9 at 12:12 PM
Port Everglades marks commissioning of new container cranesPort Everglades marks commissioning of new container cranes
en.portnews.ru - April 7 at 11:30 AM
Valaris faces rig suspension in Saudi joint ventureValaris faces rig suspension in Saudi joint venture
investing.com - April 6 at 2:41 AM
Aramco Suspends Another Jack-Up RigAramco Suspends Another Jack-Up Rig
oedigital.com - April 5 at 4:40 PM
Suspension notice for Valaris joint ventureSuspension notice for Valaris joint venture
royalgazette.com - April 5 at 4:40 PM
Saudi Aramco suspends offshore rig deal with New York-listed playerSaudi Aramco suspends offshore rig deal with New York-listed player
upstreamonline.com - April 5 at 1:44 AM
Aramco suspends jackup contract with offshore drillerAramco suspends jackup contract with offshore driller
upstreamonline.com - April 4 at 8:43 PM
Valaris (NYSE:VAL) Shares Gap Down to $76.66Valaris (NYSE:VAL) Shares Gap Down to $76.66
marketbeat.com - April 4 at 2:02 PM
Valaris Limited (NYSE:VAL) Shares Purchased by Vanguard Group Inc.Valaris Limited (NYSE:VAL) Shares Purchased by Vanguard Group Inc.
marketbeat.com - April 3 at 4:09 AM
Valaris: Buy Despite Near-Term Jackup Market HeadwindsValaris: Buy Despite Near-Term Jackup Market Headwinds
seekingalpha.com - April 2 at 7:31 PM
VAL Quantitative Stock AnalysisVAL Quantitative Stock Analysis
nasdaq.com - April 1 at 6:26 PM
Valaris Limited (NYSE:VAL) Receives Consensus Recommendation of "Buy" from AnalystsValaris Limited (NYSE:VAL) Receives Consensus Recommendation of "Buy" from Analysts
marketbeat.com - April 1 at 4:14 AM
Four-way race in heated Petrobras tender for well intervention vesselsFour-way race in heated Petrobras tender for well intervention vessels
upstreamonline.com - March 28 at 4:58 PM
Esgian Week 12 Report: New Finds in Guyana, China and NorwayEsgian Week 12 Report: New Finds in Guyana, China and Norway
marinelink.com - March 24 at 9:59 PM
Wellington Management Group LLP Purchases 107,008 Shares of Valaris Limited (NYSE:VAL)Wellington Management Group LLP Purchases 107,008 Shares of Valaris Limited (NYSE:VAL)
marketbeat.com - March 20 at 4:39 AM
Activists Across 6 Countries Stage Day of Action Against North Sea Oil DrillingActivists Across 6 Countries Stage Day of Action Against North Sea Oil Drilling
truthout.org - March 17 at 2:06 PM
North Sea Fossil Free: Activists in 6 Countries Protest Unhinged Oil and Gas Development'North Sea Fossil Free': Activists in 6 Countries Protest 'Unhinged' Oil and Gas Development
commondreams.org - March 16 at 10:22 PM
DNB Asset Management AS Cuts Holdings in Valaris Limited (NYSE:VAL)DNB Asset Management AS Cuts Holdings in Valaris Limited (NYSE:VAL)
marketbeat.com - March 16 at 6:53 AM
Scaling innovation: Offshore players invest in carbon capture, efficiency and electrification upgrades'Scaling innovation': Offshore players invest in carbon capture, efficiency and electrification upgrades
upstreamonline.com - March 13 at 5:44 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Medifocus Inc. (MFS.V) logo

Medifocus Inc. (MFS.V)

CVE:MFS
Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus, Inc. is based in Toronto, Canada.
MOTIF BIO PLC/S logo

MOTIF BIO PLC/S

NASDAQ:MTFB
Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.
Valaris logo

Valaris

NYSE:VAL
Valaris Limited, together with its subsidiaries, provides offshore contract drilling services Gulf of Mexico, South America, North Sea, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Floaters, Jackups, ARO, and Other. It owns an offshore drilling rig fleet, which include drillships, dynamically positioned semisubmersible rigs, moored semisubmersible rig, and jackup rigs. It serves international, government-owned, and independent oil and gas. Valaris Limited was founded in 1975 and is based in Hamilton, Bermuda.